Cargando…

Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine booster

Detalles Bibliográficos
Autores principales:	Goren, Andy, Cadegiani, Flavio Adsuara, Wambier, Carlos Gustavo, Vano-Galvan, Sergio, Tosti, Antonella, Shapiro, Jerry, Mesinkovska, Natasha Atanaskova, Ramos, Paulo Müller, Sinclair, Rodney, Lupi, Omar, Hercogova, Jana, McCoy, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695567/ https://www.ncbi.nlm.nih.gov/pubmed/33308937 http://dx.doi.org/10.1016/j.mehy.2020.110439

Ejemplares similares

Androgenetic alopecia in COVID-19: Compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign
por: Wambier, Carlos Gustavo, et al.
Publicado: (2020)

Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
por: Wambier, Carlos Gustavo, et al.
Publicado: (2020)

Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial
por: Cadegiani, Flavio A, et al.
Publicado: (2021)

Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial
por: McCoy, John, et al.
Publicado: (2021)

SARS-CoV-2 infection in patients with thyroid disease: a cross-sectional study
por: Nguyen, Cristina, et al.
Publicado: (2021)

Reply to: “Comment on ‘Androgenetic alopecia present in the majority of patients hospitalized with COVID-19’”
por: Wambier, Carlos G.
Publicado: (2021)

Early COVID-19 therapy with azithromycin plus nitazoxanide, ivermectin or hydroxychloroquine in outpatient settings significantly improved COVID-19 outcomes compared to known outcomes in untreated patients
por: Cadegiani, F.A., et al.
Publicado: (2021)

Mesotherapy with Dutasteride in the Treatment of Androgenetic Alopecia
por: Saceda-Corralo, David, et al.
Publicado: (2017)

Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical)
por: Cadegiani, Flavio A, et al.
Publicado: (2021)

Androgenetic alopecia in COVID-19: Compared to what?
por: Nanes, Benjamin A.
Publicado: (2020)

Development of Frontal Fibrosing Alopecia with a History of Alopecia Areata
por: Lin, Jessica, et al.
Publicado: (2018)

At the crossroads of 2 alopecias: Androgenetic alopecia pattern of hair regrowth in patients with alopecia areata treated with oral Janus kinase inhibitors
por: Yale, Katerina, et al.
Publicado: (2020)

The AndroCoV Clinical Scoring for COVID-19 Diagnosis: A Prompt, Feasible, Costless, and Highly Sensitive Diagnostic Tool for COVID-19 Based on a 1757-Patient Cohort
por: Cadegiani, Flavio A, et al.
Publicado: (2021)

Comment on “Androgenetic alopecia present in the majority of patients hospitalized with COVID-19”
por: Bukovac, Domen, et al.
Publicado: (2021)

Male balding as a major risk factor for severe COVID-19: A possible role for targeting androgens and transmembrane protease serine 2 to protect vulnerable individuals
por: Wambier, Carlos Gustavo, et al.
Publicado: (2020)

Androgenetic alopecia: An update
por: Ntshingila, Sincengile, et al.
Publicado: (2023)

Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19
por: Cadegiani, Flavio A., et al.
Publicado: (2020)

Evaluation of hair regrowth after minoxidil and dutasteride tattooing in men with androgenetic alopecia
por: Ragi, Sara D., et al.
Publicado: (2023)

Association of androgenetic alopecia with a more severe form of COVID-19 infection
por: Veskovic, Dunja, et al.
Publicado: (2022)

Suspected Herpes Zoster-associated Encephalitis during Treatment with Oral Tofacitinib in Alopecia Universalis
por: Hosking, Anna-Marie, et al.
Publicado: (2018)

Identifying first-degree family members in patients with frontal fibrosing alopecia and lichen planopilaris in a specialty alopecia clinic
por: Devjani, Shivali, et al.
Publicado: (2023)

Digital health platforms expand access and improve care for male androgenetic alopecia
por: Young, Peter C., et al.
Publicado: (2022)

Androgenetic alopecia: new insights into the pathogenesis and mechanism of hair loss
por: Sinclair, Rodney, et al.
Publicado: (2015)

Time of onset and duration of post-COVID-19 acute telogen effluvium
por: Abrantes, Tatiana F., et al.
Publicado: (2021)

Characteristics of Androgenetic Alopecia in Asian
por: Lee, Won-Soo, et al.
Publicado: (2012)

Oxidative stress in androgenetic alopecia
por: Prie, BE, et al.
Publicado: (2016)

Trichoscopic Findings in Androgenetic Alopecia
por: Kasumagic-Halilovic, Emina
Publicado: (2021)

Androgenetic Alopecia: Therapy Update
por: Devjani, Shivali, et al.
Publicado: (2023)

Reply to comment on: The Gabrin sign
por: Wambier, Carlos Gustavo, et al.
Publicado: (2021)

Trichoscopy for the Hair Transplant Surgeon—Assessing for Mimickers of Androgenetic Alopecia and Preoperative Evaluation of Donor Site Area
por: Issa, Naiem T., et al.
Publicado: (2021)

Therapeutic response of facial papules and inflammation in frontal fibrosing alopecia to low-dose oral isotretinoin
por: Pham, Christine T., et al.
Publicado: (2020)

COVID-19: Is there a weaker sex?
por: Gómez-Ochoa, Sergio Alejandro, et al.
Publicado: (2020)

Topical Melatonin for Treatment of Androgenetic Alopecia
por: Fischer, Tobias W, et al.
Publicado: (2012)

Role of Caffeine in the Management of Androgenetic Alopecia
por: Bansal, Manish, et al.
Publicado: (2012)

Involvement of Mechanical Stress in Androgenetic Alopecia
por: Tellez-Segura, Rafael
Publicado: (2015)

Platelet-Rich Plasma in Androgenetic Alopecia
por: Sharma, Aseem, et al.
Publicado: (2021)

Regenerative Medicine Treatments for Androgenetic Alopecia
por: Mysore, Venkataram, et al.
Publicado: (2021)

Adipose transcriptome in the scalp of androgenetic alopecia
por: Cruz, Criselda Jean G., et al.
Publicado: (2023)

Combination and Rotational Therapy in Androgenetic Alopecia
por: Mysore, Venkatram, et al.
Publicado: (2023)

Comparison of quality of life in patients with androgenetic alopecia and alopecia areata
por: Gonul, Muzeyyen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6minc4vfp8d3h1b0ekb4ghn5q7